Raffles Medical Group Ltd
RAFLF
$0.8073
$0.05737.64%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.76% | 2.88% | 16.19% | 17.46% | -2.40% |
| Total Other Revenue | -- | -- | -23.39% | -22.55% | -- |
| Total Revenue | 7.76% | 2.88% | 16.05% | 17.33% | -2.40% |
| Cost of Revenue | 5.75% | 0.97% | 12.53% | 13.77% | -1.05% |
| Gross Profit | 10.22% | 5.23% | 20.64% | 21.96% | -4.00% |
| SG&A Expenses | 11.68% | 6.63% | 15.33% | 16.60% | 31.06% |
| Depreciation & Amortization | 15.78% | 10.54% | 22.87% | 24.23% | 3.56% |
| Other Operating Expenses | 9.56% | 4.60% | 7.90% | 9.09% | 77.98% |
| Total Operating Expenses | 8.11% | 3.22% | 13.54% | 14.79% | 9.14% |
| Operating Income | 4.97% | 0.22% | 40.42% | 41.97% | -46.68% |
| Income Before Tax | 5.32% | 0.56% | 7.48% | 8.66% | -45.22% |
| Income Tax Expenses | -4.49% | -8.81% | 19.40% | 20.71% | -31.41% |
| Earnings from Continuing Operations | 9.28% | 4.34% | 3.46% | 4.60% | -49.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -28.48% | -22.68% | 166.88% | 167.60% | 49.98% |
| Net Income | 9.10% | 4.17% | 5.57% | 6.73% | -49.34% |
| EBIT | 4.97% | 0.22% | 40.42% | 41.97% | -46.68% |
| EBITDA | 6.17% | 1.37% | 49.62% | 51.27% | -36.70% |
| EPS Basic | 9.84% | 3.23% | 6.67% | 8.33% | -49.17% |
| Normalized Basic EPS | 5.66% | 0.00% | 43.90% | 43.90% | -45.36% |
| EPS Diluted | 11.67% | 6.67% | 6.67% | 6.67% | -49.58% |
| Normalized Diluted EPS | 5.66% | 1.89% | 43.90% | 43.90% | -45.36% |
| Average Basic Shares Outstanding | -0.18% | -0.18% | -0.14% | -0.14% | -0.06% |
| Average Diluted Shares Outstanding | -1.64% | -1.64% | -0.49% | -0.49% | 0.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.01% | -0.01% | -- | -- | 0.23% |